Atelocollagen-mediated systemic delivery prevents immunostimulatory adverse effects of siRNA in mammals.
about
AMIGO2, a novel membrane anchor of PDK1, controls cell survival and angiogenesis via Akt activation.Correlating animal and human phase Ia/Ib clinical data with CALAA-01, a targeted, polymer-based nanoparticle containing siRNA.High-density lipoproteins for the systemic delivery of short interfering RNA.Tumor-suppressive effects of atelocollagen-conjugated hsa-miR-520d-5p on un-differentiated cancer cells in a mouse xenograft model.Development of Therapeutic-Grade Small Interfering RNAs by Chemical Engineering.RNA interference targeting carbohydrate sulfotransferase 3 diminishes macrophage accumulation, inhibits MMP-9 expression and promotes lung recovery in murine pulmonary emphysemaNonviral delivery of small interfering RNA into pancreas-associated immune cells prevents autoimmune diabetes.New aspects of gene-silencing for the treatment of cardiovascular diseasesA collagen-based scaffold delivering exogenous microrna-29B to modulate extracellular matrix remodelingTherapeutic potential of siRNA and DNAzymes in cancer.Sodium chloride promotes tissue inflammation via osmotic stimuli in subtotal-nephrectomized mice.Sustained delivery of siRNA/PEI complex from in situ forming hydrogels potently inhibits the proliferation of gastric cancerDelivery strategies and potential targets for siRNA in major cancer typesAtelocollagen-mediated siRNA delivery: future promise for therapeutic application.
P2860
Q27309773-21D7D25B-5001-44CF-932B-670ACCF8B80CQ30837863-4F64F209-B621-4BFD-95F4-0413A4A02CA4Q33786171-180DBF57-89BB-44E1-816E-595BFADF21FCQ36070235-F7040626-7198-46B0-AEE3-1E3F488FDBD2Q36174842-DFFA4971-082C-430D-8235-74A442735FF3Q36358172-C13E20E2-F033-4832-BDBC-49A8E3B51551Q36460478-560030E0-667B-468B-A723-C4F1BEB26D88Q37277425-9D298D99-5F8B-48F4-97AA-CA6BF43FCFE9Q37698445-713808B4-04F1-4142-AC93-A60789484268Q38242397-9CB95AC4-B2A8-4EB5-9D73-F1E785F34895Q38717770-13C87133-5CA2-4301-9A8A-566FADD1A5BEQ38782352-BEB97DB2-4A14-4851-A033-3B459CEFC4E2Q38853191-0746FD4B-3A91-4484-9585-9BD02F8FDEC9Q48913743-E728B6D1-4B5A-4CA3-AFC9-D5FEF67ACE6C
P2860
Atelocollagen-mediated systemic delivery prevents immunostimulatory adverse effects of siRNA in mammals.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Atelocollagen-mediated systemi ...... e effects of siRNA in mammals.
@ast
Atelocollagen-mediated systemi ...... e effects of siRNA in mammals.
@en
type
label
Atelocollagen-mediated systemi ...... e effects of siRNA in mammals.
@ast
Atelocollagen-mediated systemi ...... e effects of siRNA in mammals.
@en
prefLabel
Atelocollagen-mediated systemi ...... e effects of siRNA in mammals.
@ast
Atelocollagen-mediated systemi ...... e effects of siRNA in mammals.
@en
P2093
P2860
P356
P1433
P1476
Atelocollagen-mediated systemi ...... e effects of siRNA in mammals.
@en
P2093
Kenji Kadomatsu
Naoki Makita
Seiichi Matsuo
Shinichiro Inaba
Shunji Nagahara
Takuji Ishimoto
Yoshifumi Takei
Yuzo Tarumi
P2860
P304
P356
10.1038/MT.2011.221
P577
2011-10-25T00:00:00Z